From Our 2014 Archives
IBS, Chronic Constipation: New Guidelines Issued
By Michael W. Smith, MD
Reviewed by Arefa Cassoobhoy, MD, MPH
It's been several years since the last treatment guideline updates for either of these conditions. "It was felt that there had been significant developments in both areas," says Eamonn M.M. Quigley, MD, who co-wrote the guidelines. He is chief of gastroenterology and hepatology at Houston Methodist Hospital and Weill Cornell Medical College in Houston, Texas.
Quigley and a team of researchers reviewed the available scientific evidence for IBS and chronic constipation that is not due to a known cause (known as chronic idiopathic constipation). The guidelines were released by the American College of Gastroenterology and are published in the August issue of the American Journal of Gastroenterology.
Big Medicine Changes
Drug treatments for IBS and CC have evolved in recent years. The biggest change is the development of medicines that work directly in the digestive tract. "They do not have to be absorbed into the bloodstream to be effective in the [gastrointestinal] tract," Quigley says.
The researchers give Amitiza (lubiprostone) and Linzess (linaclotide) a strong recommendation for both conditions.
"Both of these [drugs] seem to be effective for both chronic constipation and [IBS]," Quigley says.
Diet: What You Eat Does Matter
People with IBS have been telling their doctors for years that certain foods aggravate their symptoms. The new guidelines show they were right.
"When you stand back and look, there are a number of things that do jump out," Quigley says. "The first thing is the emergence of diet as a major issue in [IBS]. For patients, this isn't new, because patients have contended for years that certain foods upset them, but we were very dismissive of that." Now though, he says, good evidence suggests that diet is important -- probably not of the cause of [IBS], but a factor in attacks.
Though specialized diets may improve symptoms in some people with IBS, the researchers give them only a weak recommendation, since there is little solid evidence to support them.
Quigley says there's enormous interest in the gluten-free diet among people with IBS, as well as evidence it may help, but the research is controversial.
The researchers also give a nod to diets low in certain types of sugars. This diet includes avoiding foods like certain fruits (apples, pears, mangos, etc.), dried fruits, honey, and sweeteners like high-fructose corn syrup.
"There is, I think, now quite good evidence that this diet can help some people," Quigley says.
Probiotics are "good" bacteria that help your digestive tract. The guidelines say they can improve symptoms such as bloating and flatulence in IBS.
The guidelines give a weak recommendation to prebiotics and synbiotics for IBS. Prebiotics are non-digestible food ingredients that help support growth of probiotic bacteria. Synbiotics are supplements that have both probiotics and prebiotics.
For both IBS and CC, fiber is a sticky issue.
"Fiber is the trickiest," Quigley says. "A person with [IBS] needs to be careful with fiber. Fiber actually makes some people worse. In constipation, the evidence on fiber, believe it or not, is also not great, though the evidence on fiber supplements is good in constipation, and to a lesser extent in [IBS]."
"I think for people with chronic constipation, slowly increasing your fiber intake is certainly a worthwhile strategy," he says. "For people with [IBS], one needs to be more cautious, because there are problems with bloating, to which these patients are very sensitive."
"A lot of the 'traditional' treatments probably do work to some extent, some more than others," Quigley says. But he points out that many of them have not undergone the thorough scientific testing that doctors look for. "You find there's not a lot of evidence to support them."
"That doesn't mean they don't work, it's just that they have not had high-quality research performed," he says. "More recently, some of the more traditional laxatives ... have actually been subjected to high-quality research and have been shown to work. I think for constipation we have quite a few alternatives."
With reporting by Larry Hand, Medscape Medical News.
SOURCES: Am J Gastroenterol, August 2014. Eamonn M.M. Quigley, MD, chief of gastroenterology and hepatology, Houston Methodist Hospital and Weill Cornell Medical College, Houston, Texas.